Lyra Therapeutics, Inc.·4

Jun 26, 5:39 PM ET

Palasis Maria 4

4 · Lyra Therapeutics, Inc. · Filed Jun 26, 2023

Insider Transaction Report

Form 4
Period: 2023-06-15
Palasis Maria
DirectorPresident & CEO
Transactions
  • Award

    Stock Option

    2023-06-15+150,000150,000 total
    Exercise: $2.99Exp: 2023-06-14Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following June 15, 2023.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4